Alexandra Karadimou

Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting

Benoit Beuselinck, Sylvie Job, Étienne Becht et al. · Clinical Cancer Research · 2015 · 300 citations · Full text

Medicine, Oncology, Pharmacology +17

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases

Benoit Beuselinck, Pascal Wolter, Alexandra Karadimou et al. · British Journal of Cancer · 2012 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)

Aristotelis Bamias, Urania Dafni, Alexandra Karadimou et al. · Annals of Oncology · 2012 · 98 citations

Medicine, Oncology, Chemotherapy +9

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib

Benoit Beuselinck, Alexandra Karadimou, Diether Lambrechts et al. · British Journal of Cancer · 2013 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic impact of baseline serum <scp>C</scp> ‐reactive protein in patients with metastatic renal cell carcinoma ( <scp>RCC</scp> ) treated with sunitinib

Benoit Beuselinck, Yann Vano, Stéphane Oudard et al. · British Journal of Urology · 2013 · 73 citations

Medicine, Oncology, Cancer Pharmacology +16